Cannabidiol Modulation of Glycine Receptors: An Emerging Mechanism for Chronic Pain Treatment
Molecular Pharmacology · 2026-11 · 100161
DOI: 10.1016/j.molpha.2026.100161 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecular Pharmacology, 2026-11. Verfasst von Huifang Han und 11 weiteren Autor:innen. Die Arbeit nennt 198 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Beijing Natural Science Foundation.
Themen: Schmerzmanagement
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- Beijing Natural Science Foundation
Zitieren
APA
Han, H., Chen, S., Gao, Z., Pang, X., Liu, H., Yao, Q., Hu, C., Lin, Y., Chi, L., Fu, C., Zou, G., & Yang, N. (2026). Cannabidiol Modulation of Glycine Receptors: An Emerging Mechanism for Chronic Pain Treatment. Molecular Pharmacology, 100161. https://doi.org/10.1016/j.molpha.2026.100161
Vancouver
Han H, Chen S, Gao Z, Pang X, Liu H, Yao Q, et al. Cannabidiol Modulation of Glycine Receptors: An Emerging Mechanism for Chronic Pain Treatment. Molecular Pharmacology. 2026:100161. doi:10.1016/j.molpha.2026.100161
BibTeX
@article{Han2026,
author = {Han, Huifang and Chen, Si and Gao, Zhenfang and Pang, Xuke and Liu, Hongzuo and Yao, Qiyue and Hu, Chunlin and Lin, Yanru and Chi, Lingyi and Fu, Chonglei and Zou, Guichang and Yang, Nana},
title = {Cannabidiol Modulation of Glycine Receptors: An Emerging Mechanism for Chronic Pain Treatment},
journal = {Molecular Pharmacology},
year = {2026},
pages = {100161},
doi = {10.1016/j.molpha.2026.100161}
}
EUVIMED